title: Nek6 suppresses the premature senescence of human cancer cells induced by camptothecin and doxorubicin treatment.
abstract: Cellular senescence plays an important role in tumor suppression. The mitotic kinase Nek6 has recently been shown to be overexpressed in various cancers and has been implicated in tumorigenesis. Previously, we reported that the down-regulation of Nek6 expression was required for p53-induced senescence. In this study, we examined the effect of Nek6 overexpression on the premature senescence of cancer cells induced by the anticancer drugs camptothecin (CPT) and doxorubicin (DOX). We found that CPT- and DOX-induced morphology changes and increases in senescence-associated β-galactosidase staining were significantly inhibited in EJ human bladder cancer cells and H1299 human lung cancer cells overexpressing HA-Nek6. DOX-induced G2/M cell cycle arrest and the reduction in cyclin B and cdc2 levels after DOX treatment were significantly reduced by Nek6 overexpression. In addition, an increase in the intracellular levels of ROS in response to DOX was also inhibited in cells overexpressing Nek6. These results suggest that the increased expression of Nek6 renders cancer cells resistant to premature senescence, and targeting Nek6 could be an efficient strategy for cancer treatment.
authors.affiliation: Department of Biochemistry, College of Medicine, Dong-A University, Busan, South Korea.
authors.forename: Hye Jin
authors.initials: HJ
authors.lastname: Jee
authors.forename: Hyun-Ju
authors.initials: HJ
authors.lastname: Kim
authors.forename: Ae Jeong
authors.initials: AJ
authors.lastname: Kim
authors.forename: Naree
authors.initials: N
authors.lastname: Song
authors.forename: Minjee
authors.initials: M
authors.lastname: Kim
authors.forename: Jeanho
authors.initials: J
authors.lastname: Yun
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D002166:Camptothecin / Q000494:pharmacology*; D045744:Cell Line, Tumor; D016922:Cellular Senescence / Q000187:drug effects*; D004317:Doxorubicin / Q000494:pharmacology*; D006801:Humans; D000072379:NIMA-Related Kinases; D009369:Neoplasms / Q000378:metabolism*; D017346:Protein Serine-Threonine Kinases / Q000096:biosynthesis* / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents; D004317:Doxorubicin; C459456:NEK6 protein, human; D000072379:NIMA-Related Kinases; D017346:Protein Serine-Threonine Kinases; D002166:Camptothecin